Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Observational

Attitudes of Dental Students Towards HIV+ Patients: a Multi-center Survey Among Italian Universities

NCT07485374 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2026-02-22
Last updated
2026-03-20

Condition(s) studied

HIV (Human Immunodeficiency Virus)

Investigational drug(s) / intervention(s)

Questionnaire

Questionnaire: An anonymous questionnaire, accompanied by an informative letter, will be developed to this purpose, describing the aim of the study. The questionnaire was structured into four sections. The first section investigates personal demographic data. The second section evaluates the relationship between students and HIV-positive patients. The third section evaluates the student's knowledge of the HIV infection and the source of his knowledge. The fourth section investigates the application of the preventive operative protocols to avoid cross-infections

Study summary

The purpose of this multicentric study was to assess the attitude of Italian dental students towards HIV-infected patients. In particular, the level of discomfort perceived during the treatment, any discriminatory attitude on their part, their level of knowledge of the disease and the application of the sterilization protocols to avoid professional exposure and cross-infections.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion criteria * Completion of the survey * Dentistry students in Italy * Subjects aged ≥ 18 years Exclusion criteria * No completion of the survey * Students of degree courses different from dentistry * Subjects aged ≤ 18 years

Primary outcome measure(s)

  • Number of Italian dental students with a discriminatory behavior towards HIV positive patients — Baseline
    Students answering positively to the question "Do you think you have ever adopted a discriminatory behavior towards seropositive patients?", whenever asked to treat an HIV positive patient will be cathegorized as having a discriminatory behavior (Dichotomous variable)

Trial sites (1)

FacilityCityRegionStatus
Policlinico Universitario Fondazione Agostino Gemelli - Roma Roma RM

Other trials for the same condition

Impact of Covid-19 on Syphilis Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07485374 on ClinicalTrials.gov ↗ ← All trials in Italy